LINZESS is widely available on commercial plans with few restrictions1,*

98% of national commercial lives are covered or better. With the LINZESS savings program, commercially insured patients may pay only $30 for a 30-, 60-, or 90-day prescription
Over 5 million patients across indications have been 
prescribed LINZESS1,2

Source: IQVIA Total Patient Tracker (TPT). February 2024. Data are subject to change.

Source: Market Access Account Managers (MAT) and MMIT as of April 2024. Covered or better is defined as those lives that are Preferred and Covered with and without restrictions. Data are not a guarantee of coverage, or partial or full payment, by any payers listed.


Actual benefits determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurers. Formulary coverage does not imply efficacy or safety.

Managed Markets Insight and Technology, LLC™, a trademark of MMIT.

*2% of commercial lives are not covered and 32% are restricted as of April 2024.1

See formulary status in your area


Select a filter
please provide valid zip code

Filter your results in ZIPcode by plan type:

  • Plan Name
  • Plan Type
  • LINZESS tier

Formulary status information is valid as of February 2025. Coverage is subject to change. Some plan clients may make independent coverage decisions. Kaiser Permanente is not included in access numbers.

Samples & savings
Additional resources